Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature review.
Journal
Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
10
11
2022
revised:
31
01
2023
accepted:
02
02
2023
medline:
25
4
2023
pubmed:
9
2
2023
entrez:
8
2
2023
Statut:
ppublish
Résumé
Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.
Identifiants
pubmed: 36754140
pii: S1075-9964(23)00022-7
doi: 10.1016/j.anaerobe.2023.102713
pii:
doi:
Types de publication
Review
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
102713Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/00044409
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10353
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10356
Pays : United Kingdom
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest relevant to this article.